# Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck

> **NCT00180921** · PHASE2 · UNKNOWN · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 30 (estimated)

## Conditions studied

- Cancer of the Head and Neck
- Carcinoma, Adenoid Cystic

## Interventions

- **DRUG:** Imatinib

## Key facts

- **NCT ID:** NCT00180921
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2007-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00180921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00180921, "Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00180921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*